• Ghostalmedia@lemmy.world
    link
    fedilink
    English
    arrow-up
    36
    ·
    1 year ago

    I wonder if, even at this early stage of the therapy’s development, this would actually be more affordable than the alternative.

    Melanoma patients are highly likely to have the cancer come back and or metastasize. Repeat treatments and hospitalizations are not cheap.

    • Overzeetop@lemmy.world
      link
      fedilink
      English
      arrow-up
      34
      arrow-down
      6
      ·
      edit-2
      1 year ago

      Which is why the Moderna vaccine will be priced at just 95% of the cost of the repeat treatments and hospitalization plus the value of the time saved and pain and suffering avoidance by the patient. Say, an extra half a million. I mean, what price would you put on avoiding seeing your parent or child subjected to round after round of chemotherapy?